Cargando…
Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study
SIMPLE SUMMARY: Current treatments for complex diseases, including cancer, are generally characterized by high toxicity due to their low selectivity for target cells. Moreover, patients often develop drug resistance, hence becoming less sensitive to the therapy. For this reason, novel, improved, and...
Autores principales: | Federico, Antonio, Fratello, Michele, Scala, Giovanni, Möbus, Lena, Pavel, Alisa, del Giudice, Giusy, Ceccarelli, Michele, Costa, Valerio, Ciccodicola, Alfredo, Fortino, Vittorio, Serra, Angela, Greco, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028433/ https://www.ncbi.nlm.nih.gov/pubmed/35454948 http://dx.doi.org/10.3390/cancers14082043 |
Ejemplares similares
-
DREAM: an R package for druggability evaluation of human complex diseases
por: Federico, Antonio, et al.
Publicado: (2023) -
Nextcast: A software suite to analyse and model toxicogenomics data
por: Serra, Angela, et al.
Publicado: (2022) -
Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach
por: Saarimäki, Laura Aliisa, et al.
Publicado: (2022) -
A multi-view genomic data simulator
por: Fratello, Michele, et al.
Publicado: (2015) -
MVDA: a multi-view genomic data integration methodology
por: Serra, Angela, et al.
Publicado: (2015)